|

Therapeutic Effects of Jing Si Herbal Tea for COPD

RECRUITINGEarly 1Sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Actively Recruiting
PhaseEarly 1
SponsorTaipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Started2022-01-01
Est. completion2024-12-31
Eligibility
Age20 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06584786

Summary

Chronic obstructive pulmonary disease (COPD), a leading cause of global mortality, significantly impairs health-related quality of life (HRQL). COPD is characterized by airway inflammation and lung tissue damage. Jing Si herbal tea (JSHT) is known to have anti-inflammatory effects but has not been explored for treating COPD. This study investigated the potential of JSHT as an adjuvant therapy for COPD. This randomized controlled study focused on patients with COPD in the exacerbation and stable phases. The control group received the standard treatment, and the JSHT group received the standard treatment plus JSHT. Both groups underwent HRQL assessments, blood tests, and cellular studies involving five different groups to assess the effect of JSHT on damage-associated molecular patterns (DAMPs) and inflammatory markers.

Eligibility

Age: 20 Years+Healthy volunteers accepted
Inclusion Criteria:

* COPD patients willing to enter this study

Exclusion Criteria:

* not COPD patients, no willing to enter this study

Conditions2

Airway DiseaseCOPD

Browse More Trials

COPD trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.